Concepedia

Comparison of anthracyclines used for induction chemotherapy in patients with FLT3 -ITD-mutated acute myeloid leukemia

Eun‐Ji Choi, Je‐Hwan Lee, Je‐Hwan Lee, Han‐Seung Park, Sun-Hye Ko, Eun‐Hye Hur, Juhyun Moon, Bon-Kwan Goo, Yeonhee Kim, Miee Seol,

Leukemia Research · 2018 · 25 citations · 15 references

DOI

Concepts

References

15

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

The Annals of Statistics · 1988 · 5K citations · Full text

, , +15

Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford et al. · New England Journal of Medicine · 2017 · 2.2K citations · Full text

, , +16

Anthracycline Dose Intensification in Acute Myeloid Leukemia

Hugo F. Fernández, Zhuoxin Sun, Xiaopan Yao et al. · New England Journal of Medicine · 2009 · 907 citations · Full text

, , +13

Phase I/II Study of Combination Therapy With Sorafenib, Idarubicin, and Cytarabine in Younger Patients With Acute Myeloid Leukemia

Farhad Ravandi, Jörge E. Cortes, Daniel M. Jones et al. · Journal of Clinical Oncology · 2010 · 356 citations · Full text

, , +16

A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · Blood · 2015 · 295 citations · Full text

, , +5